PT  - JOURNAL ARTICLE
AU  - Humphreys, Caitlin
AU  - Garcia-Bournissen, Facundo
AU  - Ito, Shinya
AU  - Koren, Gideon
TI  - Exposure to attention deficit hyperactivity disorder medications during pregnancy
DP  - 2007 Jul 01
TA  - Canadian Family Physician
PG  - 1153--1155
VI  - 53
IP  - 7
4099  - http://www.cfp.ca/content/53/7/1153.short
4100  - http://www.cfp.ca/content/53/7/1153.full
SO  - Can Fam Physician2007 Jul 01; 53
AB  - QUESTION An 18-year-old patient of mine, currently under treatment for attention deficit hyperactivity disorder (ADHD) with methylphenidate, just found out that she is pregnant. What are the risks for the baby when the mother uses ADHD medications during pregnancy? ANSWER Available evidence for amphetamines suggests no increased risk of malformations with use of therapeutic doses, and inadvertent exposure during pregnancy is unlikely to be harmful. Human data for methylphenidate and atomoxetine treatment in pregnancy are very limited. Documented cases do not suggest teratogenicity, but we cannot rule out this risk with the information available.